Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Eric Souther"'
Autor:
Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson
Publikováno v:
Blood. 140:12460-12461
Autor:
Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson
Publikováno v:
Blood. 140:4213-4214
Autor:
Cathy Wang, Sean Bujarski, Camilia Soof, Eric Souther, Tahmineh Safaie, Saurabh Patil, Tanya M. Spektor, Ashkon Rahbari, Mingjie Li, Eric Sanchez, James R. Berenson, Scott Jew, Marsiye Emamy-Sadr, Regina A. Swift, Tiffany Chang, Haiming Chen
Publikováno v:
British Journal of Haematology. 192:272-280
Serum B-cell maturation antigen (sBCMA) is a novel biomarker for B-cell malignancies. A normal reference range (
Autor:
Sean Bujarski, Christine Sutanto, Tanya M. Spektor, Jennifer To, Regina A. Swift, Tracy Green, Benjamin R. Eades, Marsiye Emamy‐Sadr, Eric Souther, James R. Berenson
Publikováno v:
Hematological oncologyREFERENCES. 40(2)
Previous retrospective studies have shown that serum B-cell maturation antigen (sBCMA) levels predict outcomes among patients with multiple myeloma (MM) undergoing new treatments. Specifically, baseline levels and changes during treatment of this pro
Autor:
Marsiye Emamy-Sadr, James R. Berenson, Camilia Soof, Christine Sutanto, Cathy Wang, Tahmineh Safaie, Tanya M. Spektor, Mingjie Li, Haiming Chen, Ashkon Rahbari, Bernard Regidor, Kyle Udd, Sean Bujarski, Ning Xu, Joshua Stern, Eric Souther, Regina A. Swift, Saurabh Patil
Publikováno v:
Targeted oncology. 16(4)
B-cell maturation antigen (BCMA) is expressed on malignant plasma cells from patients with multiple myeloma (MM). These patients have higher levels of serum (s)BCMA than healthy subjects, and levels correlate with disease status. The half-life of sBC
Autor:
David Daniely, Benjamin Eades, Marissa-Skye Goldwater, Eric Souther, Ning Xu, Marsiye Emamy-Sadr, Tanya M. Spektor, Cathy Wang, Haiming Chen, Scott Jew, Bernard Regidor, Regina A. Swift, Sean Bujarski, Mingjie Li, James R. Berenson
Publikováno v:
European journal of haematologyREFERENCES. 107(3)
Background Multiple myeloma (MM) patients with smoldering (S) disease are defined by a lack of CRAB/SLiM criteria but may transform into disease requiring treatment. The International Myeloma Working Group risk stratification model for SMM uses serum
Autor:
Haiming Chen, Tahmineh Safaie, Tanya M. Spektor, Saurabh Patil, Scott Jew, Sean Bujarski, Camilia Soof, Ashkon Rahbari, Eric Souther, Marsiye Emamy-Sadr, Mingjie Li, Cathy Wang, Eric Sanchez, James R. Berenson, Regina A. Swift
Publikováno v:
British journal of haematologyReferences. 192(6)
The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. However, no study has yet established a reference range for sBCMA levels. Its levels were determined in 196 healthy subject
Autor:
Eric Souther, Jasmin Cao, James R. Berenson, Cara Wallingford, Marissa Goldwater, Mingjie Li, Ava Hekmati, Stacy Behare, Haiming Chen, Rocky Levin, Ning Xu
Publikováno v:
Blood. 138:4709-4709
Introduction: Panobinostat (Secura Bio) is a non-selective histone deacetylase inhibitor (HDACi) that has shown anti-tumor activity in preclinical studies in both solid and hematological malignancies. Duvelisib (Secura Bio) is an FDA-approved oral dr
Publikováno v:
Journal for Artistic Research.
Autor:
Joshua Stern, Marsiye Emamy-Sadr, Saurabh Patil, Eric Souther, Tahmineh Safaie, Tanya M. Spektor, Camilia Soof, Cathy Wang, Mingjie Li, Eric Sanchez, James R. Berenson, Sean Bujarski, Ning Xu, Kyle Udd, Regina A. Swift, Ashkon Rahbari, Haiming Chen
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e173-e174